| Characteristic | Number of unique Rx drugs excluded |
|---|---|
| Autonomic and central nervous system | 225 |
| Diabetes, endocrine, metabolic, and weight loss | 209 |
| Dermatological | 151 |
| Oncology, hematological, and antineoplastic/immunosuppressant | 117 |
| Cardiovascular | 109 |
| Gastrointestinal | 82 |
| Musculoskeletal, rheumatology, and osteoarthritis | 80 |
| Respiratory | 78 |
| Obstetrical and gynecological | 65 |
| Ophthalmic | 64 |
| Antivirals and anti-infectives | 61 |
| Ear/nose/throat/mouth and allergies | 32 |
| Urological | 28 |
| Inflammatory conditions | 20 |
| Hepatitis | 17 |
| Immunomodulators and transplant | 9 |
| Nephrology and renal disease | 8 |
| Hepatology | 2 |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
May 2022
More information
Region
United States
Survey time period
2014 to 2022
Supplementary notes
This statistic includes the leading three PBMs: CVS Caremark, Express Scripts, and Optum Rx. The total number — 1,357 — is higher than the 1,156 total for 2022 because some drugs were excluded and then added back to the formulary.
Citation formats
